|
LOC285033 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.9087955922289E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74950054443457E-10 |
| Normal-vs-Stage2 |
3.84589999957718E-07 |
| Normal-vs-Stage3 |
1.37619915463461E-11 |
| Normal-vs-Stage4 |
2.06239469946468E-11 |
| Stage1-vs-Stage2 |
5.868000E-01 |
| Stage1-vs-Stage3 |
1.392950E-01 |
| Stage1-vs-Stage4 |
6.311800E-02 |
| Stage2-vs-Stage3 |
1.579390E-01 |
| Stage2-vs-Stage4 |
8.592100E-02 |
| Stage3-vs-Stage4 |
5.045800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32830438157339E-11 |
| Normal-vs-AfricanAmerican |
2.018500E-04 |
| Normal-vs-Asian |
3.27200000427297E-08 |
| Caucasian-vs-AfricanAmerican |
2.822200E-01 |
| Caucasian-vs-Asian |
6.207200E-01 |
| AfricanAmerican-vs-Asian |
5.795000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.54880577649419E-12 |
| Normal-vs-Female |
2.01029970448019E-10 |
| Male-vs-Female |
4.390000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64369645566853E-11 |
| Normal-vs-Age(41-60Yrs) |
1.55431223447522E-14 |
| Normal-vs-Age(61-80Yrs) |
4.7047998830152E-10 |
| Normal-vs-Age(81-100Yrs) |
1.039450E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.788800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.314400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.634000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.610200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.797800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.601800E-02 |
| Classical-VS-Follicular |
2.217600E-01 |
| Classical-VS-Other |
9.001800E-01 |
| Classical-VS-Normal |
1.03980046795016E-10 |
| Tall-VS-Follicular |
1.631520E-02 |
| Tall-VS-Other |
5.387800E-01 |
| Tall-VS-Normal |
1.34250388583723E-11 |
| Follicular-VS-Other |
7.795800E-01 |
| Follicular-VS-Normal |
3.50559999917621E-08 |
| Other-VS-Normal |
7.896800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0565328873754E-12 |
| Normal-vs-N1 |
5.2199355948801E-12 |
| N0-vs-N1 |
1.850480E-02 |
|
|
